Your browser doesn't support javascript.
loading
Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
Soares Martins, Tânia; Trindade, Dário; Vaz, Margarida; Campelo, Inês; Almeida, Martim; Trigo, Guilherme; da Cruz E Silva, Odete A B; Henriques, Ana Gabriela.
Afiliação
  • Soares Martins T; Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Trindade D; Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Vaz M; Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Campelo I; Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Almeida M; Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Trigo G; Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • da Cruz E Silva OAB; Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Henriques AG; The Discovery CTR, University of Aveiro Campus, Aveiro, Portugal.
J Neurochem ; 156(2): 162-181, 2021 01.
Article em En | MEDLINE | ID: mdl-32618370
ABSTRACT
Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exossomos / Doença de Alzheimer Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: J Neurochem Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exossomos / Doença de Alzheimer Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: J Neurochem Ano de publicação: 2021 Tipo de documento: Article